Hikma Pharmaceuticals PLC (LON:HIK)
London
· Delayed Price · Currency is GBP · Price in GBp 1,594.00
+4.00 (0.25%)
At close: Dec 5, 2025
Hikma Pharmaceuticals Market Cap
Hikma Pharmaceuticals has a market cap or net worth of 3.53 billion as of December 5, 2025. Its market cap has decreased by -18.37% in one year.
Market Cap
3.53B
Enterprise Value
4.50B
Revenue
2.35B
Ranking
n/a
PE Ratio
13.09
Stock Price
1,594.00
Market Cap Chart
Since November 2, 2005, Hikma Pharmaceuticals's market cap has increased from 469.64M to 3.53B, an increase of 651.63%. That is a compound annual growth rate of 10.56%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 212.35B |
| GSK plc | 73.57B |
| Haleon | 32.16B |
| Smith & Nephew | 10.46B |
| Convatec Group | 4.46B |
| HUTCHMED (China) | 1.85B |
| Genus | 1.73B |
| Oxford Nanopore Technologies | 1.27B |